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the DNA was extracted from a suffi-
ciently pure, clonally related tumor cell
population. It should also be noted that
over a third of our samples had multiple
copies of the 4q12 locus. These copy
number increases are expected to affect
selectively any mutated allele as we
have demonstrated previously for KIT
(Curtin et al., 2006) and BRAF (Mal-
donado et al., 2003). The increased
dosage of the mutated allele allows the
detection of such mutations even in a
significant excess of normal cells. We
cannot exclude the possibility that
undetected mutations may be present
in a minority of cells; however, the
relevance of such mutations would be
unclear as these cells would not have
been clonally selected. In situ hybridi-
zation for PDGFRA mRNA was per-
formed on 14 samples with adequate
residual sample. Increased PDGFRA
expression was observed in 5/14 sam-
ples, but was not linked to increased
copy number of the 4q12 locus (Table
S2). The absence of PDGFRA mutations
in melanomas with and without in-
creased copy number of 4q12 in
melanomas without other known mito-
gen-activated protein kinase abnormal-
ities, together with our previous
observation that KIT mutations are
commonly found in melanomas of the
acral, mucosal and CSD types, suggests
that KIT and not PDGFRA is the
relevant gene in melanoma that drives
the selection of copy number increases
of the locus. Whether the increased
expression of PDGFRA that occurs in
some melanomas can be exploited
therapeutically needs to be shown.
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TO THE EDITOR
The association between infection by
the human T-cell lymphotropic virus
types 1 (HTLV-1) and 2 (HTLV-2) and
the most common form of cutaneous
T-cell lymphoma called mycosis fun-
goides (MF), along with its leukemic
variant called Se´zary syndrome (SS), is
unclear. In both MF and SS, antibodies
against HTLV-1 structural proteins and
HTLV-1/-2 DNA sequences have been
detected in peripheral blood mono-
nuclear cells (PBMCs), cutaneous biop-
sies (Hall et al., 1991; Whittaker and
Luzzatto, 1993; Zucker-Franklin,
Abbreviations: HTLV-1/2, human T-cell lymphotropic virus type 1/type 2; MF, mycosis fungoides;
SS, Se´zary syndrome
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2001), and saliva (Morozov et al.,
2005). HTLV-1 tax sequences have also
been detected in PBMCs of healthy
donors (Zucker-Franklin and Pancake,
1998). However, these original obser-
vations need to be confirmed; further-
more, the relationship between the
presence of HTLV sequences and clini-
cal outcome for the MF/SS patients is
not known.
This study was performed on
Italian patients affected by cutaneous
T-cell lymphoma (CTCL) (n¼66) in the
forms of large-plaque parapsoriasis
(n¼8), MF (n¼45), and SS (n¼13)
for DNA sequences associated with
HTLV-1/-2. Large-plaque parapsoriasis
is generally considered a common
initial form of MF (Cerroni et al.,
2005), whereas it is unclear whether
SS is a separate disease or, as others
claim, the ‘‘leukemic form’’ of MF. This
lack of clarity stems from the fact that
SS diagnosis is sometimes preceded by
cutaneous lesions that resemble large-
plaque parapsoriasis or, in turn, MF
patches (Cerroni et al., 2005). Patient
records and outcomes for this study are
summarized in Table S1 (see Supple-
mentary Material). The study was con-
ducted with institutional approval of
the experiments, patient consent, and
adherence to the Declaration of Hel-
sinki principles.
Serological analyses, which were
performed according to the HTLV
European Research Network algorithm
(1996), yielded negative results for
HTLV-1/-2 antibodies in both patients
and controls (data not shown). HTLV-
1/-2 gag, env, and pol sequences were
undetectable in both PBMCs and cuta-
neous biopsies from all patients when
tested by PCR/Southern blot (data not
shown). Control PBMCs of 35 healthy
blood donors, and cutaneous biopsies
from 13 patients affected by benign
inflammatory cutaneous disorders were
also negative.
PCR analysis of tax sequences per-
formed on MF cutaneous biopsies
yielded a positive result in one patient,
who presented with a granulomatous
form (no. 11MF, Table S1). All samples
were tested by SB, using the SK45 probe
specific for an HTLV-1/2-tax common
region. An SK45-positive signal was
evident in 2/45 MF patients (5.3%)
(nos. 11MF and 18MF), whereas no
HTLV sequences were detected in
large-plaque parapsoriasis patients
(Figure 1a). Interestingly, patient no.
11MF was the only case, in our cohort
of eight cases of granulomatous MF,
who showed disease progression. Simi-
larly, patient no. 18MF, diagnosed with
a classical form of MF, evolved from
stage IB to III in a few months and then
to death, in spite of stage-related treat-
ments (photo-chemotherapy, interferon-a,
and chemotherapy). The copy number
of the HTLV-tax sequence present in
the cutaneous biopsy of patient no.
11MF was further evaluated by Syber
green real-time PCR (for methods, see
Lee et al., 2004). Using quantified DNA
from C10 and C344Mo HTLV cell lines
as standard, we estimated about 25
copies of tax per 105 cells (data not
shown). However, tax sequences were
not detected in PBMCs, clinically un-
affected skin, or a reactive lymph node
from the same patient. Positive results
were found only in the affected tissue.
In SS patients, an SK45-positive signal
was detected in skin (8/11), and in
PBMC (2/6) (Figure 1a). According to
the histopathological features of cuta-
neous lymphomas, SS patients showed a
relatively poor dermo-epidermic atypi-
cal lymphocyte infiltrate with respect to
MF cases. This may reflect the lower
PCR-SB signal intensity obtained in SS
biopsies compared with MF specimens.
To define more precisely the size of
the tax sequence detected in our
samples, external primers to SK43 (nt
6798–6819; AY818420) and SK44 (nt
7591–7571; AY818420) were used to
amplify a 790-bp DNA fragment (Moro-
zov et al., 2005). The failure to detect
tax with the external primers suggests
that the tax-like sequences present in
our CTCL patients have a length bet-
ween 159 and 790bp.
When 159-bp amplimers of patients
11MF and 18 MF were sequenced and
aligned using the BLAST database, the
two MF amplimers were found to
share 100% homology with a portion
of the tax gene of HTLV-2 isolates
and 85% homology with the tax gene
of HTLV-1 isolates (Figure 1b). The
sequence that is detected in the patients
is localized in the functional domain
of the tax gene that controls the
subcellular localization of the tax pro-
tein (Turci et al., 2006), and is impor-
tant for cellular gene transactivation
through cyclic-AMP response element
binding protein (CREB)/activating trans-
cription factor (ATF) CREB/ATF or
nuclear factor-kappa B (NF-kB) signal-
ing pathways (Feuer and Green, 2005).
The amplimers of SS patients could not
be sequenced because of the low
quantity of DNA obtained from biop-
sies, and the patient’s death during
follow-up.
The presence of infiltrating T cells in
CTCL and the possible involvement of
tax-like sequences in disease progres-
sion points to the possibility that altered
production of cytokines may influence
tumor phenotype and growth. We have
determined the plasma expression
levels of 15 cytokines (IL-2, IL-4, IL-6,
IL-8, IL-10, GM-CSF, IFN-g, tumor
necrosis factor-a , IL-1b, IL-5, IL-7,
IL-12, IL-13, IL-17, G-CSF) in seven
tax2-like positive and seven tax2-like
negative CTCL subjects, as well as in
healthy donors. Fourteen of the 15
cytokines were upregulated in tax-posi-
tive versus tax-negative groups and in
tax-positive versus donors groups (P-
value o0.05). IL-7 was the single
downregulated cytokine. A lower differ-
ence in cytokine expression patterns
was observed in tax-negative, when
compared to healthy subjects, with the
exception of IL-17 and IL-7 (Figure 1c).
The two tax2-like positive MF cases
presented the same cytokine pattern as
did the SS cases. The data suggest that
the two different cytokine patterns
occurring in CTCL appeared to be
characterized by the presence or ab-
sence of tax2-like sequences. As this
sequence was absent in almost all MF
cases, but present in nearly all SS cases,
presence of the tax2-like sequence
could be a marker for disease status.
However, since IL-7 and IL-17, both
tax-inducible cytokines (Dodon et al.,
2004), are secreted similarly in both MF
and SS patients (Ciree et al., 2004), the
presence of tax2-like sequence is not
required for the modulation of their
expression. MF skin contains high levels
of IL-6, which is another tax-inducible
cytokine (Galli et al., 2004). In our tax2-
negative patients, IL-6 levels were in the
normal range, but significantly elevated
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in the tax2-positive group. IL-6 appears
to be involved in the recruitment of
lymphocytes into non-lymphoid tissues,
including the skin (Watson et al., 1996).
Therefore, its role could be cellular
recruitment in MF, but it has a signifi-
cant systemic function in SS patients. Of
note is the finding that SS patients have
a cytokine production profile typical
of the effector CD4þ Th-17 lineage
(Weawer et al., 2006). Studies are in
progress to understand the role of IL-7 as
a growth factor for Se´zary cells.
In this study, we have explored the
presence of HTLV tax-like sequences in
CTCL and hypothesized a possible role
as a negative prognostic marker for
disease progression in MF/SS. The basis
of the hypothesis is its absence in large-
plaque parapsoriasis patients, its spora-
dic detection in MF patients with
disease progression, and its high fre-
quency in blood and skin of SS patients.
Our results show unambiguously
that MF and SS patients are harboring
an HTLV-2, rather than HTLV-1, tax-
like sequence. These data are consistent
with the report that HTLV-2, but
not HTLV-1, is prevalent in southern
Europe (Salemi et al., 1996; Toro et al.,
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Figure 1. HTLV tax-like sequences and cytokine expression levels in CTCL patients. (a) PCR analysis of HTLV tax proviral sequences from PBMC and
frozen skin biopsies from CTCL patients. DNA extraction was performed by a Nucleon kit (Amersham Biosciences, Buckinghamshire, UK) for the extraction of
genomic DNA. DNA quality was confirmed by electrophoresis on 0.8% agarose gel before PCR analysis, which was performed by using 200 ng of genomic
DNA for each sample. HTLV-1/-2 tax/rex region was amplified with primers SK43 (nt 7248–7267; M10060) and SK44 (nt 7406–7386; M10060), which detect
a conserved tax/rex region of 159 bp. DNA preparations extracted from both C10 (HTLV-1-positive) and C344Mo (HTLV-2-positive) cell lines were used
as positive controls. For Southern blot analysis we used the SK45 biotinylated probe (nt 7349–7369; M10060). Lanes 1–8. Large-plaque parapsoriasis samples;
lanes 9–18: mycosis fungoides samples; lanes 54–58, 61–66: Se´zary syndrome cutaneous samples; lanes 59b, 60b, 62b, and 63b–65b: PBMC samples from
Se´zary syndrome patients. The results for the remaining MF patients are not included in the figure as they are all negative. (b) Multiple sequence alignment by
BLAST database (http://www.ncbi.nlm.nih.gov/BLAST), of HTLV-1 and HTLV-2 isolates with amplimers from patients nos. 11MF and 18MF . The amplimers of
no. 11MF were directly sequenced on ABIPRISM377–96 (Applied Biosystem, Foster City, CA), whereas the sample of no. 18MF with a lower tax intensity was
cloned in pCR4-TOPO vector (Invitrogen, Carlsbad, CA) before being sequenced. The sequence of MF amplimers was aligned with the following HTLV-1
(AF259264) and HTLV-2 (Gu, accession no. X89270) isolates. The alignment was constructed with the ClustalW software, keeping the default options suggested
by the EBI server (http://www.ebi.ac.uk/clustalw/). Visualization was enhanced with the Jalview software. Colors denote each nucleotide type, and the degree of
consensus observed in each column is indicated in the black box below. (c) Representative cytokine results from tax-like positive and tax-like negative patients.
Panel c represents the expression levels of 15 cytokines in plasma (pg/ml) of tax-like positive patients (taxþ ), tax-like negative patients (tax–), and healthy donors
(H) measured simultaneously by Luminex technology (Bio-Plex Protein Array System, Bio-Rad, San Francisco, CA). In each panel, cytokine levels are visualized
as box-and-whiskers plots and the corresponding colors (blue, green, and pink) are different when the three groups of patients presented a statistically significant
difference (e.g., in the panel corresponding to IL-7 expression, the results obtained for H, tax, and taxþ are significantly different, thus showing different
colors). Using Mann–Whitney statistical analysis, pairwise comparisons were performed. A two-tailed P-value of less than 0.05 was statistically significant.
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2005). A unique case of HTLV-2-related
MF has been described (Zucker-Franklin
et al., 1992), but it was reported as
an HTLV-2 infection, rather than as a
patient who was carrying an endogen-
ous sequence. Our findings are against
a previous HTLV-2 infection and a
defective provirus, in tissues and PBMC
of CTCL patients.
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